Health Technology · Pharmaceuticals: Major · NSE: SMSPHARMA · data 2026-10-09

SMS Pharmaceuticals Limited

Health check: Strong (7.3/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹444.65

Market cap

₹4,185 cr

P/E

39.5

P/B

—

ROE

14.3%

ROCE

13.9%

Debt / equity

0.46

Dividend yield

0.09%

1-year return

66.5%

52-week high

₹494.45

52-week low

₹270.1

Operating margin

14.8%

Growth

Revenue (last 12 months)	₹898 cr
Net profit (last 12 months)	₹102 cr
Sales growth, 3 years (yearly)	19.3%
Profit growth, 3 years (yearly)	—

Chart patterns

Cup and handle — forming (key level ₹447.8)

Similar companies

RPG Life Sciences Limited (RPGLIFE) · Gufic Biosciences Limited (GUFICBIO) · Zota Health Care Ltd. (ZOTA) · Aarti Drugs Limited (AARTIDRUGS) · Unichem Laboratories Limited (UNICHEMLAB)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SMSPHARMA in NSE Scanner →